Advertisement
Review article| Volume 22, ISSUE 4, P849-862, December 2002

Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy

      Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE) in cattle are classified as transmissible spongiform encephalopathies (TSEs) or prion diseases. TSEs are rapidly progressive, invariably fatal, neurodegenerative diseases that occur in humans and many animal species. Most TSEs are characterized by a long incubation period, and a neuropathologic feature of spongiosis, gliosis, neuronal loss, and absence of inflammatory reaction. CJD is the most common form of TSE in humans and occurs in many countries of the world, with an annual incidence of about 1 case per million population. Other human TSEs endemic in many countries include Gerstmann–Sträussler–Scheinker syndrome and fatal familial insomnia, diseases that are primarily associated with specific prion protein gene mutations and an autosomal dominant inheritance pattern [
      • Belay E.D.
      Transmissible spongiform encephalopathies in humans.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Belay E.D.
        Transmissible spongiform encephalopathies in humans.
        Annu Rev Microbiol. 1999; 53: 283-314
        • Will R.G.
        • Ironside J.W.
        • Zeidler M.
        • et al.
        A new variant of Creutzfeldt-Jakob disease in the UK.
        Lancet. 1996; 347: 921-925
        • Collee J.G.
        • Bradley R.
        BSE: a decade on—part 1.
        Lancet. 1997; 349: 636-641
        • Miller M.W.
        • Williams E.S.
        • McCarty C.W.
        • et al.
        Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming.
        J Wild Dis. 2000; 36: 676-690
        • Prusiner S.B.
        Prions.
        in: Fields B.N. Knipe D.M. Howley P.M. Fields virology. 3rd edition. Lippincott–Raven Publishers, Philadelphia1996: 2901-2950
        • Prusiner S.B.
        An introduction to prion biology and diseases.
        in: Prusiner S.B. Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY)1999: 1-66
        • Hadlow W.J.
        Scrapie and kuru.
        Lancet. 1959; 274: 289-290
        • Gajdusek D.C.
        Infectious amyloides: subacute spongiform encephalopathies as transmissible cerebral amyloidoses.
        in: Fields B.N. Knipe D.M. Howley P.M. Fields virology. 3rd edition. Lippincott–Raven Publishers, Philadelphia1996: 2851-2900
        • Van Duijn C.M.
        • Delasnerie-Lauprêtre N.
        • Masullo C.
        • et al.
        Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993–95.
        Lancet. 1998; 351: 1081-1085
        • Wientjens D.P.W.M.
        • Davanipour Z.
        • Hofman A.
        • et al.
        Risk factors for Creutzfeldt–Jakob disease: a reanalysis of case-control studies.
        Neurology. 1996; 46: 1287-1291
        • Will R.G.
        • Alpers M.P.
        • Dormont D.
        • Schonberger L.B.
        • Tateishi J.
        Infectious and sporadic prion diseases.
        in: Prusiner S.B. Prion biology and diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY)1999: 465-507
        • Cohen C.H.
        • Valleron A.J.
        When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt–Jakob disease (nvCJD) epidemic.
        Int Epidemiol Assoc. 1999; 28: 526-531
        • Department for Environment
        Food and Rural Affairs, United Kingdom.
        (Available at:) (Accessed October 9, 2002.)
        • Brown P.
        Bovine spongiform encephalopathy and variant Creutzfeldt–Jakob disease.
        BMJ. 2000; 322: 841-844
        • Nathanson N.
        • Wilesmith J.
        • Griot C.
        Bovine spongiform encephalopathy (BSE): Causes and consequences of a common source epidemic.
        Am J Epidemiol. 1997; 145: 959-969
        • Brown P.
        • Will R.G.
        • Bradley R.
        • Asher D.M.
        • Detwiler L.
        Bovine spongiform encephalopathy and variant Creutzfeldt–Jakob disease: background, evolution, and current concerns.
        Emerg Infect Dis. 2001; 7: 6-16
        • Schonberger L.B.
        New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
        Infect Dis Clin North Am. 1998; 12: 111-121
        • Collee J.G.
        • Bradley R.
        BSE: a decade on—part 2.
        Lancet. 1997; 349: 715-721
        • Office International Des Epizooties
        (Available at:) (Accessed October 9, 2002.)
        • European Commission
        (Available at:) (Accessed October 22, 2001.)
        • Animal and Plant Health Inspection Service
        US Department of Agriculture.
        (Available at:) (Accessed October 9, 2002.)
        • Nightingale S.L.
        Ruminant-to-ruminant feeding ban proposed to reduce risk of transmissible spongiform encephalopathies.
        JAMA. 1997; 277: 370
      1. Department of Health. United Kingdom. Available at: http://www.doh.gov.uk/cjd/cjd_stat.htm. Accessed October 9, 2002.

      2. Institut de Veille Sanitaire. France. Available at: http://www.invs.sante.fr/publications/default.htm. Accessed October 9, 2002.

        • Andrews N.J.
        • Farrington C.P.
        • Cousens S.N.
        • et al.
        Incidence of variant Creutzfeldt–Jakob disease in the UK.
        Lancet. 2000; 356: 481-482
        • Ghani A.C.
        • Ferguson N.M.
        • Donnelly C.A.
        • Anderson R.M.
        Predicted vCJD mortality in Great Britain.
        Nature. 2000; 406: 583-584
      3. Leicestershire Health Authority. England. Available at: http://www.leics-ha.org.uk. Accessed October 23, 2001.

      4. The National CJD Surveillance Unit and Department of Infectious and Tropical Diseases. London School of Hygiene and Tropical Medicine. Creutzfeldt–Jakob disease surveillance in the UK. Ninth Annual Report, 2000. London, United Kingdom.

        • Lorains J.W.
        • Henry C.
        • Agbamu D.A.
        • et al.
        Variant Creutzfeldt–Jakob disease in an elderly patient.
        Lancet. 2001; 357: 1339-1340
        • Will R.G.
        • Zeidler M.
        • Stewart G.E.
        Diagnosis of new variant Creutzfeldt–Jakob disease.
        Ann Neurol. 2000; 47: 575-582
        • Zeidler M.
        • Sellar R.J.
        • Collie D.A.
        • et al.
        The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt–Jakob disease.
        Lancet. 2000; 355: 1412-1418
        • Ironside J.W.
        Neuropathological findings in new variant CJD and experimental transmission of BSE.
        FEMS Immunol Med Microbiol. 1998; 21: 91-95
        • Hill A.F.
        • Zeidler M.
        • Ironside J.
        • Collinge J.
        Diagnosis of new variant Creutzfeldt–Jakob disease by tonsil biopsy.
        Lancet. 1997; 349: 99-100
        • Hill A.F.
        • Butterworth R.J.
        • Joiner S.
        • et al.
        Investigation of variant Creutzfeldt–Jakob disease and other human prion diseases with tonsil biopsy samples.
        Lancet. 1999; 353: 183-189
        • Wadsworth J.D.F.
        • Joiner S.
        • Hill A.F.
        • et al.
        Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay.
        Lancet. 2001; 358: 171-180
        • Schonberger L.B.
        New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: the strengthening etiologic link between two emerging diseases.
        in: Scheld W.M. Craig W.A. Hughes J.M. Emerging infections. American Society for Microbiology, Washington, DC1998: 1-5
        • Scott M.R.
        • Will R.
        • Ironside J.
        • et al.
        Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans.
        Proc Natl Acad Sci USA. 1999; 96: 15137-15142
        • Bruce M.E.
        • Will R.G.
        • Ironside J.W.
        • et al.
        Transmission to mice indicate that “new variant” CJD is caused by the BSE agent.
        Nature. 1997; 389: 498-501
        • Food and Drug Administration
        (Available at:) (Accessed October 22, 2001.)
        • Centers for Disease Control and Prevention
        Surveillance for Creutzfeldt–Jakob disease—United States.
        MMWR Morb Mortal Wkly Rep. 1996; 45: 665-668
        • Gibbons R.V.
        • Holman R.C.
        • Belay E.D.
        • Schonberger L.B.
        Creutzfeldt–Jakob disease in the United States: 1979–1998.
        JAMA. 2000; 284: 2322-2323
        • Holman R.C.
        • Khan A.S.
        • Belay E.D.
        • Schonberger L.B.
        Creutzfeldt–Jakob disease in the United States, 1979–1994: using national mortality data to assess the possible occurrence of variant cases.
        Emerg Infect Dis. 1996; 2: 333-337
        • National Prion Disease Pathology Surveillance Center
        (Available at:) (Accessed October 9, 2002.)